Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors

  • Authors:
    • Hironori Shiozaki
    • Yoshihiro Shirai
    • Takashi Horiuchi
    • Jungo Yasuda
    • Kenei Furukawa
    • Shinji Onda
    • Takeshi Gocho
    • Hiroaki Shiba
    • Toru Ikegami
  • View Affiliations

  • Published online on: April 3, 2021     https://doi.org/10.3892/mco.2021.2273
  • Article Number: 111
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pancreatic neuroendocrine tumor (PNET) cases are increasing; however, the treatment indication and procedure remain unestablished. The present study evaluated the indication, feasibility and safety of laparoscopic distal pancreatectomy (LDP) with our technique for PNET. A total of 13 patients with insulinoma and nonfunctional PNET <2 cm in diameter who underwent LDP and 13 patients with any size of PNET who underwent open distal pancreatectomy (ODP) between October 2009 and June 2019 were retrospectively reviewed and compared. The median age of patients was 45 (33‑61) years, and 14 (54%) patients were male. The median follow‑up periods were 70 months for the LDP group and 46 months for the ODP group. The tumor diameter of the patients who underwent LDP for PNET was 18±9 mm compared with 37±25 mm for those who underwent ODP. The operation time, estimated blood loss, and complication were 290.2±115 vs. 337±131 min (P=0.338), 122±172 vs. 649±693 ml (P=0.019) and 31 vs. 54% (P=0.234), respectively. Pancreatic fistula developed in 8% of patients who underwent LDP compared with 31% who underwent ODP (P=0.131). Notably, the postoperative hospitalization period was significantly shorter in the LDP group (11±7 vs. 21±13 days; P=0.022). Tumor grade of 2017 World Health Organization classification (G1/G2/G3/NEC/unknown) was 9/2/0/0/2 for the LDP group compared with 5/5/0/3/0 for the ODP group. Furthermore, lymph node metastasis was detected in only 1 patient who underwent ODP, for whom the maximum tumor diameter was 70 mm and was classified as G2. In addition, 2 patients in the ODP group developed postoperative lung and liver metastases. LDP for PNETs of <2 cm in selected patients can be safely performed; however, the extent of lymph node dissection needs to be clarified.
View Figures
View References

Related Articles

Journal Cover

June-2021
Volume 14 Issue 6

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shiozaki H, Shirai Y, Horiuchi T, Yasuda J, Furukawa K, Onda S, Gocho T, Shiba H and Ikegami T: Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors. Mol Clin Oncol 14: 111, 2021
APA
Shiozaki, H., Shirai, Y., Horiuchi, T., Yasuda, J., Furukawa, K., Onda, S. ... Ikegami, T. (2021). Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors. Molecular and Clinical Oncology, 14, 111. https://doi.org/10.3892/mco.2021.2273
MLA
Shiozaki, H., Shirai, Y., Horiuchi, T., Yasuda, J., Furukawa, K., Onda, S., Gocho, T., Shiba, H., Ikegami, T."Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors". Molecular and Clinical Oncology 14.6 (2021): 111.
Chicago
Shiozaki, H., Shirai, Y., Horiuchi, T., Yasuda, J., Furukawa, K., Onda, S., Gocho, T., Shiba, H., Ikegami, T."Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors". Molecular and Clinical Oncology 14, no. 6 (2021): 111. https://doi.org/10.3892/mco.2021.2273